Denali Therapeutics Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · South San Francisco, CA
DNLI chart
What traders are saying about $DNLI
Latest postsDenali Therapeutics Inc. news
- Wedbush cuts target for Denali Therapeutics stock from USD 27 to USD 23
ad-hoc-news.de ·
- Wedbush cuts Denali target to USD 23 for Denali Therapeutics stock
ad-hoc-news.de ·
- Denali Therapeutics Inc. Estimates – NASDAQ:DNLI
TradingView ·
- Denali Therapeutics Inc. (DNLI) stock price, news, quote and history
Yahoo Finance UK ·
- Denali Therapeutics (DNLI) Institutional Ownership 2026 $DNLI
MarketBeat ·
- Denali Therapeutics to report Q3 2026 financial results on November 3, 2026
Pluang ·
- Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026
Yahoo Finance ·
- DNLI stock: November 5 results date guides Denali Therapeutics stock
ad-hoc-news.de ·
- Denali Therapeutics (Nasdaq:DNLI) - Stock Analysis
Simply Wall Street ·
- Can RARE's Approved Product Portfolio Drive Its Next Growth Phase?
Yahoo Finance ·
- Pompe Disease Market Set for Expansion During the Forecast Period (2026-2036) as Growth is Fueled by Next-Generation ERTs, Newborn Screening, and Pipeline Innovation | DelveInsight
Yahoo Finance ·
- Is Denali Therapeutics (DNLI) Reasonably Valued On Future Cash Flow?
Yahoo Finance ·
Denali Therapeutics Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $330.5M | $105.1M |
| Net income | -$512.5M | -$422.8M | -$145.2M | -$326.0M |
| Diluted EPS | $-2.97 | $-2.57 | $-1.06 | $-2.60 |
| Total assets (year end) | $1.14B | $1.37B | $1.15B | $1.46B |
| Cash and equivalents (year end) | $205.3M | $175.0M | $127.1M | $218.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Denali Therapeutics Inc.
- Ticker
- DNLI (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1714899
Frequently asked questions
What exchange is Denali Therapeutics Inc. listed on?
Denali Therapeutics Inc. trades on the Nasdaq under the ticker symbol DNLI.
What industry is Denali Therapeutics Inc. in?
Denali Therapeutics Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Denali Therapeutics Inc. headquartered?
Denali Therapeutics Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does Denali Therapeutics Inc.'s fiscal year end?
Denali Therapeutics Inc.'s fiscal year ends on December 31.
How much revenue did Denali Therapeutics Inc. report?
Denali Therapeutics Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.